Skip to main content

Table 4 Antimicrobial Resistance Rates in all Hospitals

From: The 2017 global point prevalence survey of antimicrobial consumption and resistance in Canadian hospitals

Multidrug-resistant organism Number of patients treated for MDRO Prevalence of MDRO (%, number of patients treated for MDRO on number of patients receiving antimicrobials for therapeutic use (CAI and HAI))
MRSA 29 2.7
MRCoNS 6 0.6
VRE 10 0.9
ESBL 20 1.8
3-ceph 11 1.0
CRE 0  
ESBL-NF 2 0.2
CR-NF 2 0.2
Other MDRO 19 1.7
  1. Abbreviations: 3-ceph 3rd generation cephalosporin resistant Enterobacteriaceae (non-ESBL or ESBL status unknown), CAI community-acquired infection, CRE carbapenem-resistant Enterobacteriaceae, CR-NF carbapenem-resistant non-fermenter Gram-negative bacilli, ESBL bacteria producing extended-spectrum beta-lactamases, ESBL-NF ESBL-producing non-fermenter Gram-negative bacilli, HAI healthcare-associated infection, MDRO multi-drug resistant organism, MRCoNS methicillin-resistant coagulase negative staphylococci, MRSA methicillin-resistant Staphylococcus aureus, VRE Vancomycin-resistant enterococci